BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LAM-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LAM-001\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06018766-550@assetmemo.bio
DTSTAMP:20261121T004102Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:LAM-001: Phase 2 readout est. (NCT06018766)
DESCRIPTION:LAM-001\, phase 2\, Bronchiolitis Obliterans Syndrome.\nStudy: 
 LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndro
 me.\nEstimated primary completion: December 2026. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/lam-001#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06018766
URL:https://assetmemo.bio/drug/lam-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05798923-550@assetmemo.bio
DTSTAMP:20261121T004102Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:LAM-001: Phase 2 readout est. (NCT05798923)
DESCRIPTION:LAM-001\, phase 2\, Pulmonary Hypertension Associated with Inte
 rstitial Lung Disease.\nStudy: LAM-001 for the Treatment of Pulmonary Hype
 rtension Associated With Interstitial Lung Disease (PH-ILD)\nEstimated pri
 mary completion: March 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/lam-001#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT05798923
URL:https://assetmemo.bio/drug/lam-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07886554-550@assetmemo.bio
DTSTAMP:20261121T004102Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:LAM-001: Phase 2 readout est. (NCT07886554)
DESCRIPTION:LAM-001\, phase 2.\nStudy: LAM-001 for the Treatment of Sarcoid
 osis Associated Pulmonary Hypertension (SAPH)\nEstimated primary completio
 n: December 2028. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/lam
 -001#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NC
 T07886554
URL:https://assetmemo.bio/drug/lam-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
